Substance · official US FDA label
Ketotifène (ketotifen)
7 medicines listed on Vimpia contain it, alone or combined. Below, the official US FDA label for ketotifen, unchanged.
Want to buy it?
Trouver shows the pharmacies near you that have it right now, and their prices. The reservation pages are in French.
This is a US label.
The official US FDA label for ketotifen (published as KETOTIFEN FUMARATE), effective August 31, 2026, describes products sold in the United States. The medicine sold in DR Congo may differ in strength, form or approved uses: ask a pharmacist or a doctor.
Official US FDA label for ketotifen
Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. The full label on DailyMed.
Uses
Uses For the temporary relief of itchy eyes due to ragweed, pollen, grass, animal hair and dander.
Dosage
US dosage, for products sold in the United States. For a medicine bought in DR Congo, follow its box, its leaflet or your pharmacist.
Directions adults and children 3 years and older: put 1 drop in the affected eye(s) twice daily, every 8-12 hours, no more than twice per day if using other ophthalmic products while using this, wait at least 5 minutes between each product Children under 3 years of age: consult a doctor
Warnings and precautions
Warnings For external use only Do not use if you are sensitive to any ingredient in this product if solution changes color or becomes cloudy to treat contact lens related irritation When using this product remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use do not touch tip of container to any surface to avoid contamination replace cap after each use Stop use and ask a doctor if you experience any of the following: eye pain changes in vision redness of the eyes itching that worsens or lasts for more than 72 hours
Medicines that contain it
Names as they are sold. A medicine without an English page links to its French page.
- KETAZED 0,25 mg/mL, collyre en solution
- MONOKETO 0,25 mg/ml, collyre en solution en récipient unidose
- ZADITEN 1 mg/5 ml, solution buvable
- ZADITEN L.P. 2 mg, comprimé pelliculé à libération prolongée
- ZAGRAPA 0,25 mg/ml, collyre en solution
- ZAGRAPA 0,25 mg/ml, collyre en solution en récipient unidose
- ZALERG 0,25 mg/ml, collyre en solution
Sources
- ●Labels: U.S. Food and Drug Administration, openFDA (public domain). Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. DailyMed.
- ●English names of substances: RxNorm, U.S. National Library of Medicine.
- ●Marketing authorizations: register of the ACOREP, DR Congo.
- ●Essential medicines: national list of essential medicines of DR Congo (LNME).
- ●Composition: public medicines database of France (BDPM), ANSM, open licence.
Public information, for reference only: it does not replace the advice of a pharmacist or a doctor. Vimpia writes nothing about how to use a medicine and translates nothing: the label is the US FDA's, unchanged; names, composition and authorizations come from the official sources above.